17 beta-carbothioate 17-alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents, process for their preparation and pharmaceutical compositions containing them
Abstract
The subject of the invention is compounds of general formula (I), their salts and solvates - in the formula, R1 is C1-6 alkyl or C1-6 haloalkyl-, R2 is -C(=O)-aryl- or -C(=O)- heteroaryl-, R3 is a hydrogen atom, methyl (this can be in the a or b configuration) or methylene group, R4 and R5 are the same or different and are hydrogen or halogen, and _ _ _ is a single or double bond. The invention also applies to the pharmaceutical preparations containing the compounds of general formula (I) above, to the use of the compounds and pharmaceutical preparations as human and veterinary medicine, to the production process of the compounds, and to the new intermediates used in the production process. HE

Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
15 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15
275 members in 42 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 0019172 | United Kingdom | A | |
| 0108800 | United Kingdom | A | |
| 0103499 | United Kingdom | W |
Members275
| Document | Office | Kind | |
|---|---|---|---|
| GB0019172D0 | United Kingdom | D0 | |
| GB0108800D0 | United Kingdom | D0 | |
| CA2417825A1 | Canada | A1 | |
| CA2417826A1 | Canada | A1 | |
| CA2634715A1 | Canada | A1 | |
| DZ3468A1 | Algeria | A1 | |
| WO0212265A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0212266A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7576001A | Australia | A | |
| AU7649701A | Australia | A | |
| US2002165211A1 | United States of America | A1 | |
| US2002173496A1 | United States of America | A1 | |
| US2002177581A1 | United States of America | A1 | |
| NO20030549D0 | Norway | D0 | |
| NO20030549L | Norway | L | |
| NO20030550D0 | Norway | D0 | |
| US2003045512A1 | United States of America | A1 | |
| US6537983B1 | United States of America | B1 | |
| AP2003002731A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| ECSP034470A | Ecuador | A | |
| NO20030550L | Norway | L | |
| KR20030028806A | Republic of Korea | A | |
| US2003073676A1 | United States of America | A1 | |
| EP1305329A1 | European Patent Office (EPO) | A1 | |
| EP1305330A1 | European Patent Office (EPO) | A1 | |
| CZ2003353A3 | Czechia | A3 | |
| US2003092690A1 | United States of America | A1 | |
| MXPA03001096A | Mexico | A | |
| MXPA03001097A | Mexico | A | |
| SK1422003A3 | Slovakia | A3 | |
| US2003109511A1 | United States of America | A1 | |
| BR0113042A | Brazil | A | |
| BR0113039A | Brazil | A | |
| IL154148A0 | Israel | A0 | |
| IL154148D0 | Israel | D0 | |
| IL154175A0 | Israel | A0 | |
| IL154175D0 | Israel | D0 | |
| US2003144257A1 | United States of America | A1 | |
| US2003153542A1 | United States of America | A1 | |
| WO03066024A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066026A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066032A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066033A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066036A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066656A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200302831A | Taiwan Province of China | A | |
| EA200300082A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CO5310534A1 | Colombia | A1 | |
| CO5310550A1 | Colombia | A1 | |
| AU2003205850A1 | Australia | A1 | |
| AU2003205855A1 | Australia | A1 | |
| AU2003207016A1 | Australia | A1 | |
| AU2003207019A1 | Australia | A1 | |
| AU2003244450A1 | Australia | A1 | |
| AU2003244506A1 | Australia | A1 | |
| KR20030071751A | Republic of Korea | A | |
| BG107518A | Bulgaria | A | |
| MA25899A1 | Morocco | A1 | |
| US2003199485A1 | United States of America | A1 | |
| AR032361A1 | Argentina | A1 | |
| AR032471A1 | Argentina | A1 | |
| HU0303084A2 | Hungary | A2 | |
| HUP0303084A2This record | Hungary | A2 | |
| CN1468252A | China | A | |
| CN1468253A | China | A | |
| TW200400837A | Taiwan Province of China | A | |
| HU0303354A2 | Hungary | A2 | |
| HUP0303354A2 | Hungary | A2 | |
| WO2004009613A1 | World Intellectual Property Organization (WIPO) | A1 | |
| HK1056180A | Hong Kong, China | A | |
| HK1056180A1 | Hong Kong, China | A1 | |
| HK1056181A | Hong Kong, China | A | |
| HK1056181A1 | Hong Kong, China | A1 | |
| AU2003253354A1 | Australia | A1 | |
| US2004028615A1 | United States of America | A1 | |
| JP2004505989A | Japan | A | |
| JP2004505990A | Japan | A | |
| WO2004024745A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003266390A1 | Australia | A1 | |
| AU2003266390A8 | Australia | A8 | |
| ZA200300932B | South Africa | B | |
| US6750210B2 | United States of America | B2 | |
| US6759398B2 | United States of America | B2 | |
| OA12394A | African Intellectual Property Organization (OAPI) | A | |
| ZA200300929B | South Africa | B | |
| US6777399B2 | United States of America | B2 | |
| US6777400B2 | United States of America | B2 | |
| PL359917A1 | Poland | A1 | |
| PL359999A1 | Poland | A1 | |
| US6787532B2 | United States of America | B2 | |
| EP1471884A1 | European Patent Office (EPO) | A1 | |
| EP1471895A1 | European Patent Office (EPO) | A1 | |
| EP1471896A1 | European Patent Office (EPO) | A1 | |
| EP1471900A1 | European Patent Office (EPO) | A1 | |
| EP1472272A1 | European Patent Office (EPO) | A1 | |
| US2004220156A1 | United States of America | A1 | |
| US2004220157A1 | United States of America | A1 | |
| US2004220162A1 | United States of America | A1 | |
| US2004224931A1 | United States of America | A1 | |
| US2004224932A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Lapse of provisional protection due to non-payment of feesLapsedFD9A | FD9A |
Numbers
- Application
- 303084
Titles2
- English
- 17 BETA-CARBOTHIOATE 17-ALPHA-ARYLCARBONYLOXYLOXY ANDROSTANE DERIVATIVE AS ANTI-INFLAMMATORY AGENTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
- Hungarian
- Gyulladásgátló hatású 17béta-karbotioát-17alfa-arilkarboniloxiloxi androsztán-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
Classification
- CPC, 20
- C07J31/006
- C07J31/00
- A61P1/04
- A61P1/08
- A61P11/00
- A61P11/02
- A61P11/06
- A61P11/08
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/06
- A61P19/02
- A61P27/02
- A61P27/14
- A61P29/00
- A61P37/08
- A61P43/00
- A61P5/00
- A61P5/44
- IPC, 18
- A61K9 12
- A61K9 14
- A61K31 56
- A61K31 58
- A61K45 00
- A61K47 06
- A61K47 18
- A61K47 36
- A61P5 44
- A61P11 06
- A61P11 08
- A61P29 00
- A61P37 08
- A61P43 00
- C07J17 00
- C07J31 00
- C07J33 00
- C07J43 00